CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
Authors
Keywords
Ovarian cancer, Chemoresistance, Il-6, Mesenchymal stromal cell, Mouse
Journal
Molecular Cancer
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-15
DOI
10.1186/s12943-018-0787-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-6 Mediates Macrophage Infiltration after Irradiation via Up-regulation of CCL2/CCL5 in Non-small Cell Lung Cancer
- (2017) Xin Wang et al. RADIATION RESEARCH
- A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors
- (2016) Toshio Shimizu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling
- (2016) Denis Lane et al. Molecular Cancer
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
- (2015) E. M. Dijkgraaf et al. ANNALS OF ONCOLOGY
- SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction
- (2015) Jennifer Pasquier et al. BMC CANCER
- Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer
- (2015) C. S. Milagre et al. CANCER RESEARCH
- Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro
- (2015) T.T. Piltonen et al. HUMAN REPRODUCTION
- A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2015) Suzanne F. Jones et al. INVESTIGATIONAL NEW DRUGS
- Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche
- (2015) Pegah Ghiabi et al. Journal of Translational Medicine
- Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma
- (2015) M B Meads et al. ONCOGENE
- Interleukin-6-dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction
- (2014) Julia Müller et al. BASIC RESEARCH IN CARDIOLOGY
- Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer
- (2014) Nina R. Shah et al. GYNECOLOGIC ONCOLOGY
- Sphingosine-1-Phosphate Mediates COX-2 Expression and PGE2/IL-6 Secretion via c-Src-Dependent AP-1 Activation
- (2014) Chih-Kai Hsu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile
- (2014) Raphael Lis et al. Journal of Translational Medicine
- Role of mesenchymal cells in the natural history of ovarian cancer: a review
- (2014) Cyril Touboul et al. Journal of Translational Medicine
- Akt-Activated Endothelium Constitutes the Niche for Residual Disease and Resistance to Bevacizumab in Ovarian Cancer
- (2014) B. S. Guerrouahen et al. MOLECULAR CANCER THERAPEUTICS
- FAK Inhibition Disrupts a 5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
- (2014) I. Tancioni et al. MOLECULAR CANCER THERAPEUTICS
- Mesenchymal stem cell secretome and regenerative therapy after cancer
- (2013) Ludovic Zimmerlin et al. BIOCHIMIE
- Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line
- (2013) NADIA BENABBOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model
- (2013) Cyril Touboul et al. Journal of Translational Medicine
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages
- (2012) Magali Castells et al. CANCER LETTERS
- Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression
- (2012) Kristy K. Ward et al. CLINICAL & EXPERIMENTAL METASTASIS
- Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion
- (2012) Kevin Anton et al. PLoS One
- Breast cancer subtypes express distinct receptor repertoires for tumor-associated macrophage derived cytokines
- (2011) Kelly S. Levano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
- (2011) Karen McLean et al. JOURNAL OF CLINICAL INVESTIGATION
- Breast Cancer Cells Induce Cancer-Associated Fibroblasts to Secrete Hepatocyte Growth Factor to Enhance Breast Tumorigenesis
- (2011) Shiaw-Wei Tyan et al. PLoS One
- Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
- (2011) Marcin P. Iwanicki et al. Cancer Discovery
- Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12
- (2010) Raphael Lis et al. INTERNATIONAL JOURNAL OF CANCER
- Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary
- (2010) Seiji Mabuchi et al. MOLECULAR CANCER THERAPEUTICS
- Tumour-microenvironmental interactions: paths to progression and targets for treatment
- (2010) Carol Box et al. SEMINARS IN CANCER BIOLOGY
- Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis
- (2009) Wen-ting Xu et al. CANCER LETTERS
- Pyk2 Inhibition of p53 as an Adaptive and Intrinsic Mechanism Facilitating Cell Proliferation and Survival
- (2009) Ssang-Taek Lim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression
- (2009) Erika L. Spaeth et al. PLoS One
- Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
- (2009) Shannon Kidd et al. STEM CELLS
- Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours
- (2008) Arash Rafii et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started